GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medpace Holdings Inc (FRA:01P) » Definitions » E10

Medpace Holdings (FRA:01P) E10 : €3.63 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Medpace Holdings E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Medpace Holdings's adjusted earnings per share data for the three months ended in Mar. 2024 was €2.944. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €3.63 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-10), Medpace Holdings's current stock price is €371.30. Medpace Holdings's E10 for the quarter that ended in Mar. 2024 was €3.63. Medpace Holdings's Shiller PE Ratio of today is 102.29.

During the past 11 years, the highest Shiller PE Ratio of Medpace Holdings was 102.38. The lowest was 94.90. And the median was 100.24.


Medpace Holdings E10 Historical Data

The historical data trend for Medpace Holdings's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medpace Holdings E10 Chart

Medpace Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medpace Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 3.63

Competitive Comparison of Medpace Holdings's E10

For the Diagnostics & Research subindustry, Medpace Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medpace Holdings's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medpace Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Medpace Holdings's Shiller PE Ratio falls into.



Medpace Holdings E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medpace Holdings's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.944/131.7762*131.7762
=2.944

Current CPI (Mar. 2024) = 131.7762.

Medpace Holdings Quarterly Data

per share eps CPI Adj_EPS
201312 0.000 98.326 0.000
201403 -0.023 99.695 -0.030
201412 0.000 99.070 0.000
201503 -0.001 99.621 -0.001
201506 0.002 100.684 0.003
201509 -0.003 100.392 -0.004
201512 -0.199 99.792 -0.263
201603 0.078 100.470 0.102
201606 0.111 101.688 0.144
201609 0.116 101.861 0.150
201612 0.000 101.863 0.000
201703 0.187 102.862 0.240
201706 0.205 103.349 0.261
201709 0.210 104.136 0.266
201712 0.253 104.011 0.321
201803 0.324 105.290 0.406
201806 0.385 106.317 0.477
201809 0.446 106.507 0.552
201812 0.536 105.998 0.666
201903 0.451 107.251 0.554
201906 0.646 108.070 0.788
201909 0.572 108.329 0.696
201912 0.702 108.420 0.853
202003 0.688 108.902 0.833
202006 0.568 108.767 0.688
202009 0.925 109.815 1.110
202012 1.110 109.897 1.331
202103 0.958 111.754 1.130
202106 0.880 114.631 1.012
202109 1.097 115.734 1.249
202112 1.168 117.630 1.308
202203 1.535 121.301 1.668
202206 1.381 125.017 1.456
202209 2.071 125.227 2.179
202212 2.001 125.222 2.106
202303 2.120 127.348 2.194
202306 1.781 128.729 1.823
202309 2.080 129.860 2.111
202312 2.256 129.419 2.297
202403 2.944 131.776 2.944

Add all the adjusted EPS together and divide 10 will get our e10.


Medpace Holdings  (FRA:01P) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Medpace Holdings's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=371.30/3.63
=102.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Shiller P/E Ratio of Medpace Holdings was 102.38. The lowest was 94.90. And the median was 100.24.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Medpace Holdings E10 Related Terms

Thank you for viewing the detailed overview of Medpace Holdings's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Medpace Holdings (FRA:01P) Business Description

Traded in Other Exchanges
Address
5375 Medpace Way, Cincinnati, OH, USA, 45227
Medpace is a late-stage contract research organization, or CRO, that provides full-service drug development and clinical trial services to small and midsized biotechnology, pharmaceutical, and medical device firms. Medpace also offers ancillary services such as bio-analytical laboratory services and imaging capabilities. The company was founded over 30 years ago, and it has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are principally based in the U.S., but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in February 2014, and it exited Medpace in August 2018.

Medpace Holdings (FRA:01P) Headlines

No Headlines